Status:

UNKNOWN

Prospective Clinical Trials to Assess Performance and Safety of EyeSwift Pro

Lead Sponsor:

NovaSight

Conditions:

Visual Functions

Eligibility:

All Genders

6+ years

Brief Summary

EyeSwift Pro assessment of visual function parameters as measured by psychophysics

Detailed Description

The following assessments and procedures will be carried out in this trial: * Baseline assessments will include the following: age, gender, ethnicity, race, education, clinical ocular diagnosis, and ...

Eligibility Criteria

Inclusion

  • ≥4 years
  • Have visual acuity better than 6/60
  • Diagnosed as having either Orthophoria or/and Heterophoria or/and Orthotropia or/and heterotopia (group A only)
  • Normal vision or visual impermeant (group C and E only)
  • Normal or deficient vergence (group D only)
  • Normal or deficient reading disabilities (group F only)
  • 8 years and older or third grade (group F only)
  • Subject in general good health and able, as per investigator decision, to comply with study visits and protocol procedures
  • Signed and dated informed consent form
  • Parent and participant understand and are willing to comply with

Exclusion

  • Anophthalmic
  • Photosensitive epilepsy or susceptible to epileptic seizures
  • Pre-existing concomitant pathology such as congenital cataracts or glaucoma (not including group E)
  • Severe developmental delay that would interfere with testing (in the opinion of the investigator). Subjects with mild speech delay or reading and/or learning disabilities are not excluded
  • Extraocular muscle (EOM) paralysis (groups A and B only)
  • Nystagmus
  • Any ocular pathology or anomalies which can interfere with eye-tracking
  • Any ocular pathology or anomalies (i.e., age-related macular degeneration (AMD), diabetic retinopathy etc.) (relevant for groups A-F, group E can include such anomalies)

Key Trial Info

Start Date :

June 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05382676

Start Date

June 1 2022

End Date

June 1 2023

Last Update

May 19 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.